Recombinant Xylella fastidiosa tRNA pseudouridine synthase A (truA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
truA; PD_0610; tRNA pseudouridine synthase A; EC 5.4.99.12; tRNA pseudouridine(38-40) synthase; tRNA pseudouridylate synthase I; tRNA-uridine isomerase I
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-257
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Xylella fastidiosa (strain Temecula1 / ATCC 700964)
Target Names
truA
Target Protein Sequence
MMRYALGVEY DGSEFLGWQQ LGEMGPSVQA TLQQALASVA DSSVRVVCAG RTDAGVHGQC QVVHFDSAVT RPPRAWILGT TTRLPSSVAV RWCVPTSEDF HARFSACARR YRYRLLNRQV RPALQHQFLS WERHPLDAQA MHVAAQMLLG ENDFSAFRSA QCQALHARRE LQAISVRRDA EVIEICVQAN AFLHHMVRNI VGSLLMVGTG ERPMEWIAEL LAGRDRTMAG PTASARGLVF VGPLYPEKWH LPMEVSV
Uniprot No.

Target Background

Function
Pseudouridine formation at positions 38, 39, and 40 within the anticodon stem-loop of transfer RNAs.
Database Links

KEGG: xft:PD_0610

Protein Families
TRNA pseudouridine synthase TruA family

Q&A

What is Xylella fastidiosa tRNA pseudouridine synthase A (truA) and what are its primary functions?

The enzyme belongs to the TruA family of pseudouridine synthases, characterized by specific structural motifs that enable RNA recognition and catalytic activity. Unlike other bacterial RNA modification enzymes, truA exhibits substrate specificity for multiple tRNA targets rather than a single modification site, making it an interesting target for understanding broad translational regulation in this plant pathogen.

How does sequence homology analysis inform our understanding of truA function across different Xylella fastidiosa strains?

Comparative sequence analysis of truA across different X. fastidiosa strains reveals highly conserved catalytic domains alongside variable regions that may correlate with host specificity. When examining truA sequences from strains that infect different hosts (almond, citrus, grapevine, and olive), researchers should employ the following methodological approach:

  • Perform multiple sequence alignment using MUSCLE or CLUSTALW algorithms

  • Identify conserved catalytic motifs versus variable regions

  • Construct phylogenetic trees to visualize evolutionary relationships

  • Map sequence variations to three-dimensional protein structure predictions

What experimental design approaches are most appropriate for studying truA function in Xylella fastidiosa?

When investigating truA function in X. fastidiosa, researchers should implement true experimental designs that incorporate random assignment, control groups, and manipulation of independent variables. This approach ensures reliable cause-and-effect relationships can be established . The following experimental design framework is recommended:

  • Random assignment of bacterial cultures or plant samples to treatment groups

  • Inclusion of multiple control groups (negative controls, positive controls, and procedural controls)

  • Careful manipulation of a single independent variable while controlling other factors

  • Rigorous measurement of dependent variables using validated assays

For studying truA's role in pathogenicity, a randomized complete block design with nested factors works effectively. This allows researchers to account for potential variations in experimental conditions while isolating the specific effects of truA expression or mutation .

When analyzing results, researchers should develop a truth table similar to the following to evaluate logical consistency in experimental outcomes:

truA ExpressionPseudouridine FormationBacterial GrowthVirulence
Normal (WT)NormalNormalNormal
OverexpressedIncreasedVariableVariable
KnockoutAbsentReducedReduced
Mutated (catalytic site)ReducedVariableReduced

This logical framework helps identify potential contradictions in experimental results and guides the development of refined hypotheses .

What are the optimal conditions for expressing recombinant Xylella fastidiosa truA in heterologous systems?

For optimal expression of recombinant X. fastidiosa truA in E. coli systems, researchers should consider the following methodological approach:

  • Vector selection: pET-based expression vectors with T7 promoter systems provide tight regulation and high expression levels for recombinant truA

  • Host strain: BL21(DE3) or Rosetta(DE3) strains are recommended, with the latter providing additional tRNAs that may improve expression of X. fastidiosa proteins

  • Induction conditions: IPTG induction at 0.5-1.0 mM when cultures reach OD600 0.6-0.8

  • Expression temperature: Reduce to 18-20°C post-induction to enhance proper folding

  • Media supplementation: Include 2% glucose to reduce basal expression and 100 μg/ml ampicillin for plasmid maintenance

The recombinant protein is typically produced as a fusion with affinity tags (His6 or GST) to facilitate purification while maintaining enzymatic activity . Expression yields of approximately 20 mg per liter of culture can be achieved under these optimized conditions.

For functional studies, researchers should verify that the recombinant truA maintains pseudouridylation activity using in vitro assays with synthetic tRNA substrates before proceeding to more complex experiments.

How does truA expression correlate with Xylella fastidiosa infection progression in plant hosts?

The expression of truA in X. fastidiosa appears to correlate with distinct phases of infection progression in plant hosts. Research indicates that truA expression patterns shift as infection advances from asymptomatic to symptomatic stages. In almond trees infected with X. fastidiosa, qPCR analysis has shown that 54% of sampled trees were infected, with bacterial loads varying significantly between asymptomatic and symptomatic plants .

Methodologically, researchers should employ a time-course experimental design to track truA expression alongside infection progression:

  • Sample collection at defined intervals (early, middle, and late infection stages)

  • Quantification of bacterial load using qPCR with primers targeting conserved X. fastidiosa genomic regions

  • RNA extraction and RT-qPCR for truA expression analysis

  • Correlation of truA expression with symptom development using a standardized disease severity index

In experimental systems, symptom development typically follows this pattern, which can be used to standardize experimental timepoints:

Disease Severity (DS)Symptoms% of TreesX. fastidiosa Detection Rate
DS = 0Asymptomatic52.7%18.8%
0 < DS ≤ 1Initial symptoms17.6%93.0%
1 < DS ≤ 2Low severity18.7%93.0%
2 < DS ≤ 3Moderate symptoms11.0%93.0%

These data indicate that while most symptomatic trees (93.0%) test positive for X. fastidiosa, a significant proportion of asymptomatic trees (18.8%) also harbor the bacterium . This suggests truA may be differentially regulated during early, asymptomatic infection versus later disease stages.

What methodologies are most effective for studying the impact of truA on X. fastidiosa interactions with microbial communities?

To investigate how truA influences X. fastidiosa's interactions with existing microbial communities in plant xylem, researchers should employ multi-omics approaches combined with network analysis. The following methodological framework is recommended:

  • Sample collection from infected and healthy plant xylem tissue

  • 16S rRNA amplicon sequencing for bacterial community analysis

  • ITS sequencing for fungal community characterization

  • Metatranscriptomics to assess differential gene expression, including truA

  • Network analysis to identify microbial interactions

Network analysis has revealed that X. fastidiosa infection reshapes microbial community structure, with principal coordinate analysis showing clear differentiation of bacterial communities between X. fastidiosa-infected and non-infected plants . Specifically, bacterial communities cluster according to X. fastidiosa infection status, with the bacterium explaining 22.8% of variation in Bray-Curtis distance measures .

When implementing this approach, researchers should construct co-occurrence networks similar to those shown in previous studies, where X. fastidiosa showed negative interactions primarily with Ascomycota fungi and certain Proteobacteria, notably Sphingomonas . These exclusionary relationships should be quantified using statistical measures such as Spearman correlation coefficients with appropriate P-value adjustments for multiple comparisons.

What advanced sequencing approaches can resolve contradictions in truA activity data across different X. fastidiosa strains?

When researchers encounter contradictory results regarding truA activity across X. fastidiosa strains, integrating multiple sequencing approaches with rigorous data analysis can resolve these inconsistencies. The following methodological framework is recommended:

  • Whole genome sequencing of multiple strains with varying truA activity profiles

  • RNA-Seq under standardized conditions to quantify transcriptional differences

  • CRISPR-Cas9 mediated genetic modification to create isogenic strains differing only in truA sequence

  • Nanopore direct RNA sequencing to identify post-transcriptional modifications

Data analysis should employ a structured approach to identify potential sources of contradictions:

Potential Source of ContradictionAnalytical MethodResolution Approach
Sequence variants in truA geneSNP and indel identificationSite-directed mutagenesis
Differential expression regulationTranscription factor binding site analysisChIP-seq for regulatory proteins
Post-translational modificationsLC-MS/MS proteomic analysisPhosphoproteomic analysis
Environmental influencesControlled environment testingFactorial experimental design

How can researchers effectively design truncation/mutation studies to identify critical functional domains in truA?

To systematically identify functional domains within X. fastidiosa truA, researchers should implement a comprehensive truncation and site-directed mutagenesis strategy. The following methodological approach is recommended:

  • Primary sequence analysis to identify conserved domains and critical residues

  • Creation of a series of N-terminal and C-terminal truncations at 10-amino acid intervals

  • Site-directed mutagenesis of catalytic residues and RNA-binding motifs

  • Expression of wild-type and mutant proteins under identical conditions

  • Functional assessment using standardized pseudouridylation assays

The experimental design should follow a true experimental approach with appropriate controls and randomization to minimize bias . Results should be analyzed using both qualitative (activity/no activity) and quantitative (kinetic parameters) metrics.

A systematic data analysis approach should include:

  • Comparison of activity levels using one-way ANOVA with post-hoc tests

  • Calculation of kinetic parameters (Km, Vmax) for each mutant

  • Correlation of activity changes with structural predictions

  • Analysis of cooperative effects through double-mutant cycles

This systematic approach allows researchers to map the relationship between truA structure and function with high precision, revealing which domains are essential for catalytic activity versus substrate recognition or protein stability.

How does environmental stress affect truA expression and function in X. fastidiosa?

Environmental stressors significantly impact X. fastidiosa pathogenicity, with truA expression potentially serving as a regulatory mechanism for adaptation. To study this relationship, researchers should implement the following experimental design:

  • Expose X. fastidiosa cultures to controlled stressors (temperature variation, osmotic stress, oxidative stress, nutrient limitation)

  • Monitor truA expression using RT-qPCR with appropriate reference genes

  • Assess pseudouridylation levels in tRNA populations using LC-MS or next-generation sequencing approaches

  • Correlate changes in truA activity with stress response pathways and virulence factor expression

Analysis of microbial community data from infected plants indicates that X. fastidiosa's interactions with other microorganisms change under environmental stress conditions. For example, the bacterium shows exclusionary relationships with certain microbial taxa that may be magnified under stress conditions .

Researchers should analyze data from these experiments using multivariate approaches that can distinguish direct environmental effects from indirect effects mediated through microbial community changes.

What role does truA play in X. fastidiosa biofilm formation in plant xylem vessels?

To investigate truA's potential role in X. fastidiosa biofilm formation, researchers should implement a methodology that combines genetic manipulation with advanced imaging techniques and transcriptomic analysis:

  • Create truA knockout and overexpression strains using CRISPR-Cas9 or traditional homologous recombination approaches

  • Culture modified strains under biofilm-inducing conditions in microfluidic chambers mimicking xylem vessels

  • Quantify biofilm formation using crystal violet staining, confocal microscopy, and biomass measurements

  • Conduct comparative transcriptomic analysis of wild-type versus modified strains under biofilm-forming conditions

When analyzing biofilm formation, researchers should consider the relationship between X. fastidiosa and other microorganisms in the xylem environment. Network analysis has shown that X. fastidiosa exhibits negative interactions with certain bacterial taxa, particularly Sphingomonas, which may compete for attachment sites in the xylem .

The experimental design should incorporate true experimental principles including random assignment and appropriate controls to establish causality rather than mere correlation . Results should be analyzed using both qualitative assessment and quantitative measurements of biofilm characteristics.

What are the most promising future research directions regarding X. fastidiosa truA in relation to disease management?

Future research on X. fastidiosa truA should focus on translating molecular insights into practical disease management strategies. The following research directions show particular promise:

  • Development of high-throughput screening methods for truA inhibitors that could serve as targeted antimicrobials

  • Investigation of environmental factors that modulate truA expression as potential disease management tools

  • Exploration of cross-talk between truA activity and plant defense responses

  • Engineering of plant microbiomes with organisms that suppress X. fastidiosa through interactions with truA-mediated processes

These approaches should build upon the established understanding that X. fastidiosa significantly reshapes microbial communities in infected plants , potentially creating opportunities for microbiome engineering as a management strategy.

Researchers should design these studies using rigorous experimental approaches that distinguish correlation from causation , ensuring that any disease management strategies developed have a solid scientific foundation.

How can contradictions in field versus laboratory studies of truA function be resolved through improved experimental design?

Resolving contradictions between field and laboratory studies requires a methodological framework that bridges controlled and natural environments. Researchers should implement the following approach:

  • Design parallel experiments in laboratory and field settings with standardized variables where possible

  • Use semi-controlled field experiments (e.g., mesh enclosures, potted plants in field conditions) as intermediate validation steps

  • Incorporate environmental monitoring in field studies to account for variables absent in laboratory settings

  • Develop mathematical models that predict how laboratory-observed mechanisms might function under variable field conditions

This approach acknowledges that variables beyond experimental control may influence truA function differently in field versus laboratory conditions. For example, microbial community interactions observed in natural orchard settings reveal complex networks of co-occurrence and mutual exclusion that may not be fully replicated in laboratory models .

Data analysis should explicitly test for environmental interaction effects using statistical approaches such as generalized linear mixed models that can account for nested and interacting variables. This comprehensive approach helps reconcile seemingly contradictory results by identifying the specific environmental or biological contexts in which each result holds true.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.